Corindus Vascular Robotics Stock Price - CVRS

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Corindus Vascular Robotics Inc CVRS AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.01 0.23% 4.28 4.28 4.27 4.27 4.27 16:10:13
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,330 301,230 $ 4.27 $ 1,286,710 1,927,259 0.78 - 4.37
Last Trade Time Type Quantity Stock Price Currency
18:29:43 20,724 $ 4.28 USD

Corindus Vascular Robotics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 893.17M 208.69M $ -34.99M -0.22 - 207.69M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
8.79M $ - 0.00% 3.00 0.50%

more financials information »

Corindus Vascular Robotics News

Loading Messages....

Latest CVRS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CVRS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week4.264.284.264.26932M0.020.47%
1 Month4.254.284.254.26422M0.030.71%
3 Months2.824.372.154.11423M1.4651.77%
6 Months2.174.371.863.62923M2.1197.24%
1 Year1.314.370.783.15982M2.97226.72%
3 Years1.024.370.40172.20501M3.26319.61%
5 Years3.564.580.40172.2119725k0.7220.22%

Corindus Vascular Robotics Description

Corindus Vascular Robotics Inc designs manufacture and sells precision vascular robotic-assisted systems used in interventional vascular procedure also called as the CorPath System. The CorPath System is the first medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures to optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Its revenue is derived from the sale of products CorPath 200 and CorPath GRX Systems.


Your Recent History
AMEX
CVRS
Corindus V..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.